Fireside Ventures Leads $5 Mn Series A Round in Skincare Brand CHOSEN

Why It Matters

The infusion of venture capital underscores growing investor confidence in science‑led, skin‑of‑color solutions and positions CHOSEN to scale domestically while entering high‑growth international markets.

Key Takeaways

• CHOSEN raised $5M Series A led by Fireside Ventures.
• Funding will boost R&D and talent for evidence‑based products.
• Brand serves 2,000+ clinics; 95% digital sales on own platform.
• 70% revenue from repeat customers, women 30‑50.
• Planning expansion into Latin America and East Asia skin‑of‑color markets.

Pulse Analysis

The $5 million Series A injection marks a pivotal moment for CHOSEN, reflecting a broader trend where venture capitalists target niche skincare segments that address under‑served demographics. Investors such as Fireside Ventures and L’Oréal’s BOLD fund see the melanin‑rich skin market in India—and similar cohorts worldwide—as ripe for scientific, evidence‑based products. By backing a brand that blends clinical dermatology with a direct‑to‑consumer (D2C) model, they aim to capture both high‑margin clinic prescriptions and scalable online sales, a hybrid approach that mitigates reliance on any single channel.

CHOSEN’s business model leverages a network of over 2,000 clinics to generate initial prescriptions, then transitions patients to its proprietary D2C platform for ongoing maintenance. This clinic‑to‑consumer pipeline fuels a remarkable 70% repeat‑purchase rate, especially among women aged 30‑50, and supports a portfolio of 58 SKUs ranging from topical treatments to nutraceuticals. The recent funding will accelerate R&D, allowing the brand to expand its Centre of Excellence and develop new clinically validated formulations, reinforcing its positioning against global players like Avène and Shiseido.

Looking ahead, CHOSEN’s ambition to enter Latin America and East Asia taps into parallel skin‑of‑color needs, promising a sizable addressable market beyond India. Successful expansion will depend on replicating its hybrid clinic‑D2C framework while navigating local regulatory landscapes. If executed well, CHOSEN could set a template for other Indian‑origin beauty tech firms seeking global scale, potentially reshaping competitive dynamics in the worldwide skin‑of‑color segment.